Hawaii Biotech News
Most Popular Hawaii Biotech Story
Merck buys vax unit from bankrupt Hawaii Biotech
Merck (NYSE: MRK) has agreed to purchase bankrupt Hawaii Biotech's dengue fever vaccine unit for an undisclosed sum. It's a critical move for Hawaii, which filed for Chapter 11 bankruptcy protection Read more...
Latest Headlines
- July 21, 2010
- December 14, 2009
- February 25, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
